Then, explain the type of treatment regimen you would recommend for treating your patient, including the choice of pharmacotherapeutics you would recommend, and explain why. Be sure to justify your response.

Then, explain the type of treatment regimen you would recommend for treating your patient, including the choice of pharmacotherapeutics you would recommend, and explain why. Be sure to justify your response.

According to Konoplia et al, 2022, the development of hyperactive states is associated with an

increase in the quantitative and functional characteristics of the effector components of immunity

and/or a lack of suppressive factors. The parameters to reduce would be, blood glucose levels at

143dL/ML on day 3 should be lowered further. High levels of white blood cells of over 10,000, as

evidenced by positive lab results of the continued presence of bacterial infection should be

responding at a faster rate to an antibacterial by day 3 of treatment. I would continue the

antibacterial treatment of Ceftriaxone 1 gm IV daily to continue the treatment of bacterial

infection, even though it was started as an empiric treatment. These features or their combinations

underlie the development of the infectious pathology of pneumonia. Ceftriaxone is in the class of

cephalosporin, and beta-lactam, which work by binding to penicillin-binding proteins. It is a

broad-spectrum bactericidal which disrupts cell wall synthesis, and activates autolysins, killing the

bacteria, (Rosenthal & Burchum, 2021).